Clinical trial NCT00202709: Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?
Official title: Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Agoraphobia
Social Phobia
PTSD
Keywords: Anxiety disorder
Thought Field Therapy
Psychotherapy
Agoraphobia
Social Phobia
Post Traumatic Stress Disorder
Lead sponsor: Sorlandet Hospital HF
Sponsor class: OTHER_GOV
First posted: 2005-09-20
Enrollment: 52
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).

Detailed description: Thought Field Therapy is an alternative treatment method that has been shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 52 patients, with one or more of the diagnoses agoraphobia, social phobia and/or PTSD, where randomized to either treatment with TFT or a wait list. The treatment group all got treatment in one week. 2 1/2 months later both the treatment group and the control group were tested on the same items as before the treatment started. After this evaluation phase the control group got the same treatment as the treatment or study group. Both groups were evaluated 3 and 12 months after treatment, the study group also 6 months after treatment. 4 patients were omitted because they changed groups. The study were performed from May 2002 until June 2003.

Eligibility criteria: Inclusion Criteria:

* One or more of the study diagnoses agoraphobia, social phobia and/or PTSD

Exclusion Criteria:

* Ongoing psychosis
* Ongoing serious drug problems

Primary outcomes:
measure: Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Secondary outcomes:
measure: Davidson Trauma Scale
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
measure: Liebowitz Social Anxiety Scale
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
measure: Hospital Anxiety and Depression Scale (HADS)
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
measure: Fear Questionnaire (FQ)
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
measure: Sheehan Disability Scale
timeFrame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.
Other outcomes:
Locations:
city: Arendal
country: Norway
facility: Sorlandet Hospital
Study officials:
affiliation: Sorlandet Hospital HF
name: Audun C Irgens, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Irgens A, Dammen T, Nysaeter TE, Hoffart A. Thought Field Therapy (TFT) as a treatment for anxiety symptoms: a randomized controlled trial. Explore (NY). 2012 Nov-Dec;8(6):331-8. doi: 10.1016/j.explore.2012.08.002.